Compare CCCC & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCC | PDLB |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.7M | 481.1M |
| IPO Year | 2020 | 2021 |
| Metric | CCCC | PDLB |
|---|---|---|
| Price | $3.73 | $20.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 59.7K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.45 | ★ 160.87 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $35,947,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.38 |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $1.69 | $13.91 |
| 52 Week High | $5.17 | $20.79 |
| Indicator | CCCC | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 51.76 |
| Support Level | $3.42 | $19.49 |
| Resistance Level | $3.91 | $20.68 |
| Average True Range (ATR) | 0.22 | 0.47 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 47.46 | 50.00 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.